These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 10524411)
1. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: toxicities and preliminary results. Tan EH; Chua ET; Wee J; Tan T; Fong KW; Ang PT; Lee KS; Lee KM; Khoo-Tan HS; Leong SS; Ong YK; Foo KF; Sethi VK; Chua EJ Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):597-601. PubMed ID: 10524411 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and feasibility of cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma. Demizu Y; Sasaki R; Soejima T; Maruta T; Okamoto Y; Yamada K; Yoden E; Ejima Y; Ota Y; Ishida H; Nibu K; Sugimura K Jpn J Clin Oncol; 2006 Oct; 36(10):620-5. PubMed ID: 16905756 [TBL] [Abstract][Full Text] [Related]
3. Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer. Bae WK; Hwang JE; Shim HJ; Cho SH; Lee JK; Lim SC; Chung WK; Chung IJ Cancer Chemother Pharmacol; 2010 Feb; 65(3):589-95. PubMed ID: 19830427 [TBL] [Abstract][Full Text] [Related]
4. Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: results of a matched cohort analysis. Chua DT; Sham JS; Au GK; Choy D Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):334-43. PubMed ID: 12023137 [TBL] [Abstract][Full Text] [Related]
5. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma. Chua DT; Sham JS; Au GK Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880 [TBL] [Abstract][Full Text] [Related]
6. Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China. Chen Y; Sun Y; Liang SB; Zong JF; Li WF; Chen M; Chen L; Mao YP; Tang LL; Guo Y; Lin AH; Liu MZ; Ma J Cancer; 2013 Jun; 119(12):2230-8. PubMed ID: 23576020 [TBL] [Abstract][Full Text] [Related]
7. Neo-adjuvant Docetaxel and Cisplatin followed by concurrent Cisplatin with radiation therapy in treatment of locally advanced nasopharyngeal carcinoma. Hassan E; Galal K; Esmat E Gulf J Oncolog; 2008 Jan; (3):46-53. PubMed ID: 20084797 [TBL] [Abstract][Full Text] [Related]
8. Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials. Lee AW; Tung SY; Ngan RK; Chappell R; Chua DT; Lu TX; Siu L; Tan T; Chan LK; Ng WT; Leung TW; Fu YT; Au GK; Zhao C; O'Sullivan B; Tan EH; Lau WH Eur J Cancer; 2011 Mar; 47(5):656-66. PubMed ID: 21112774 [TBL] [Abstract][Full Text] [Related]
9. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china. Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy. Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248 [TBL] [Abstract][Full Text] [Related]
11. Concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma of the undifferentiated type. Ong YK; Tan EH; Wee J; Goh CB; Fong KW; Lee KS; Chua EJ Ann Acad Med Singap; 1999 Jul; 28(4):525-8. PubMed ID: 10561766 [TBL] [Abstract][Full Text] [Related]
12. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. Wee J; Tan EH; Tai BC; Wong HB; Leong SS; Tan T; Chua ET; Yang E; Lee KM; Fong KW; Tan HS; Lee KS; Loong S; Sethi V; Chua EJ; Machin D J Clin Oncol; 2005 Sep; 23(27):6730-8. PubMed ID: 16170180 [TBL] [Abstract][Full Text] [Related]
13. A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Chi KH; Chang YC; Guo WY; Leung MJ; Shiau CY; Chen SY; Wang LW; Lai YL; Hsu MM; Lian SL; Chang CH; Liu TW; Chin YH; Yen SH; Perng CH; Chen KY Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1238-44. PubMed ID: 11955734 [TBL] [Abstract][Full Text] [Related]
14. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Chen L; Hu CS; Chen XZ; Hu GQ; Cheng ZB; Sun Y; Li WX; Chen YY; Xie FY; Liang SB; Chen Y; Xu TT; Li B; Long GX; Wang SY; Zheng BM; Guo Y; Sun Y; Mao YP; Tang LL; Chen YM; Liu MZ; Ma J Lancet Oncol; 2012 Feb; 13(2):163-71. PubMed ID: 22154591 [TBL] [Abstract][Full Text] [Related]
15. [Concurrent chemoradiotherapy followed by adjuvant chemotherapy for stage III-IVa nasopharyngeal carcinoma]. Hu QY; Liu P; Wang L; Fu ZF Ai Zheng; 2007 Apr; 26(4):394-7. PubMed ID: 17430659 [TBL] [Abstract][Full Text] [Related]
16. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. Lee AW; Tung SY; Chua DT; Ngan RK; Chappell R; Tung R; Siu L; Ng WT; Sze WK; Au GK; Law SC; O'Sullivan B; Yau TK; Leung TW; Au JS; Sze WM; Choi CW; Fung KK; Lau JT; Lau WH J Natl Cancer Inst; 2010 Aug; 102(15):1188-98. PubMed ID: 20634482 [TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study. Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial. Cao SM; Yang Q; Guo L; Mai HQ; Mo HY; Cao KJ; Qian CN; Zhao C; Xiang YQ; Zhang XP; Lin ZX; Li WX; Liu Q; Qiu F; Sun R; Chen QY; Huang PY; Luo DH; Hua YJ; Wu YS; Lv X; Wang L; Xia WX; Tang LQ; Ye YF; Chen MY; Guo X; Hong MH Eur J Cancer; 2017 Apr; 75():14-23. PubMed ID: 28214653 [TBL] [Abstract][Full Text] [Related]
19. Phase II trial of neoadjuvant docetaxel and cisplatin followed by intensity-modulated radiotherapy with concurrent cisplatin in locally advanced nasopharyngeal carcinoma. Zhong YH; Dai J; Wang XY; Xie CH; Chen G; Zeng L; Zhou YF Cancer Chemother Pharmacol; 2013 Jun; 71(6):1577-83. PubMed ID: 23549883 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic results of alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil: its usefulness and controversial points. Fuwa N; Ito Y; Kodaira T; Matsumoto A; Kamata M; Furutani K; Tatibana H; Sasaoka M; Morita K Jpn J Clin Oncol; 2001 Dec; 31(12):589-95. PubMed ID: 11902489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]